Related references
Note: Only part of the references are listed.The RNA-binding protein HuR in human cancer: A friend or foe
Xiaoqing Wu et al.
ADVANCED DRUG DELIVERY REVIEWS (2022)
Loxl2 and Loxl3 Paralogues Play Redundant Roles during Mouse Development
Patricia G. Santamaria et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
DAVID: a web server for functional enrichment analysis and functional annotation of gene lists (2021 update)
Brad T. Sherman et al.
NUCLEIC ACIDS RESEARCH (2022)
RNA-binding proteins and cancer metastasis
Shengjie Wang et al.
SEMINARS IN CANCER BIOLOGY (2022)
RNA-binding proteins in regulating mRNA stability and translation: roles and mechanisms in cancer
Wei Li et al.
SEMINARS IN CANCER BIOLOGY (2022)
Cytogenetic and Genetic Abnormalities with Diagnostic Value in Myelodysplastic Syndromes (MDS): Focus on the Pre-Messenger RNA Splicing Process
Nathalie Douet-Guilbert et al.
DIAGNOSTICS (2022)
TIF1? inhibits lung adenocarcinoma EMT and metastasis by interacting with the TAF15/TBP complex
Zhiyue Su et al.
CELL REPORTS (2022)
LOXL2-dependent deacetylation of aldolase A induces metabolic reprogramming and tumor progression
Ji-Wei Jiao et al.
REDOX BIOLOGY (2022)
The molecular biology of FMRP: new insights into fragile X syndrome
Joel D. Richter et al.
NATURE REVIEWS NEUROSCIENCE (2021)
Elevated FBXO45 promotes liver tumorigenesis through enhancing IGF2BP1 ubiquitination and subsequent PLK1 upregulation
Xiao-Tong Lin et al.
ELIFE (2021)
IGF2BP1, a Conserved Regulator of RNA Turnover in Cancer
Markus Glass et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2021)
RNA binding protein serine/arginine splicing factor 1 promotes the proliferation, migration and invasion of hepatocellular carcinoma by interacting with RecQ protein-like 4 mRNA
Ying Ye et al.
BIOENGINEERED (2021)
Guidelines and definitions for research on epithelial-mesenchymal transition
Jing Yang et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2020)
RNA-binding proteins in tumor progression
Hai Qin et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
Fragile X-related protein family: a double-edged sword in neurodevelopmental disorders and cancer
Mrinmoyee Majumder et al.
CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY (2020)
An RNA-Binding Protein, Hu-antigen R, in Pancreatic Cancer Epithelial to Mesenchymal Transition, Metastasis, and Cancer Stem Cells
Ruochen Dong et al.
MOLECULAR CANCER THERAPEUTICS (2020)
Transite: A Computational Motif-Based Analysis Platform That Identifies RNA-Binding Proteins Modulating Changes in Gene Expression
Konstantin Krismer et al.
CELL REPORTS (2020)
RNA-Binding Proteins in Cancer: Functional and Therapeutic Perspectives
Donghee Kang et al.
CANCERS (2020)
LOXL2 in cancer: regulation, downstream effectors and novel roles
Bing Wen et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2020)
Lysyl oxidases: Emerging biomarkers and therapeutic targets for various diseases
Nan Yang et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
Structures of SALSA/DMBT1 SRCR domains reveal the conserved ligand-binding mechanism of the ancient SRCR fold
Martin P. Reichhardt et al.
LIFE SCIENCE ALLIANCE (2020)
Lysyl oxidase-like 2 (LOXL2)-mediated cross-linking of tropoelastin
Christian E. H. Schmelzer et al.
FASEB JOURNAL (2019)
Cancer the'RBP'eutics-RNA-binding proteins as therapeutic targets for cancer
Shakur Mohibi et al.
PHARMACOLOGY & THERAPEUTICS (2019)
A brave new world of RNA-binding proteins
Matthias W. Hentze et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2018)
JMJD6 and U2AF65 co-regulate alternative splicing in both JMJD6 enzymatic activity dependent and independent manner
Jia Yi et al.
NUCLEIC ACIDS RESEARCH (2017)
Lysyl Oxidase 3 Is a Dual-Specificity Enzyme Involved in STAT3 Deacetylation and Deacetylimination Modulation
Li Ma et al.
MOLECULAR CELL (2017)
A Phase II, Randomized, Double-Blind, Placebo-Controlled Study of Simtuzumab in Combination with FOLFIRI for the Second-Line Treatment of Metastatic KRAS Mutant Colorectal Adenocarcinoma
J. Randolph Hecht et al.
ONCOLOGIST (2017)
A Phase II Randomized, Double-Blind, Placebo-Controlled Study of Simtuzumab or Placebo in Combination with Gemcitabine for the First-Line Treatment of Pancreatic Adenocarcinoma
Al B. Benson et al.
ONCOLOGIST (2017)
Pre-clinical evaluation of small molecule LOXL2 inhibitors in breast cancer
Joan Chang et al.
ONCOTARGET (2017)
Fragile X syndrome
Randi J. Hagerman et al.
NATURE REVIEWS DISEASE PRIMERS (2017)
LOXL2 drives epithelial-mesenchymal transition via activation of IRE1-XBP1 signalling pathway
Eva P. Cuevas et al.
SCIENTIFIC REPORTS (2017)
RNA-Binding Proteins in Cancer: Old Players and New Actors
Bruno Pereira et al.
TRENDS IN CANCER (2017)
The Ribonucleic Complex HuR-MALAT1 Represses CD133 Expression and Suppresses Epithelial-Mesenchymal Transition in Breast Cancer
Elisa Latorre et al.
CANCER RESEARCH (2016)
Lysyl Oxidase Isoforms and Potential Therapeutic Opportunities for Fibrosis and Cancer
Philip C. Trackman
EXPERT OPINION ON THERAPEUTIC TARGETS (2016)
Lysyl oxidase-like 2 (LOXL2) oxidizes trimethylated lysine 4 in histone H3
Nicolas Herranz et al.
FEBS Journal (2016)
CD82 suppresses CD44 alternative splicing-dependent melanoma metastasis by mediating U2AF2 ubiquitination and degradation
P. Zhang et al.
ONCOGENE (2016)
Current Evidence and Future Perspectives on HuR and Breast Cancer Development, Prognosis, and Treatment
Ioly Kotta-Loizou et al.
NEOPLASIA (2016)
Lysyl oxidase-like 2 represses Notch1 expression in the skin to promote squamous cell carcinoma progression
Alberto Martin et al.
EMBO JOURNAL (2015)
The function and mechanisms of action of LOXL2 in cancer
Linghong Wu et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2015)
LOXL2 Oxidizes Methylated TAF10 and Controls TFIID-Dependent Genes during Neural Progenitor Differentiation
Ane Iturbide et al.
MOLECULAR CELL (2015)
A Cdh1-APC/FMRP Ubiquitin Signaling Link Drives mGluR-Dependent Synaptic Plasticity in the Mammalian Brain
Ju Huang et al.
NEURON (2015)
Origin and evolution of lysyl oxidases
Xavier Grau-Bove et al.
SCIENTIFIC REPORTS (2015)
The Molecular Signatures Database Hallmark Gene Set Collection
Arthur Liberzon et al.
CELL SYSTEMS (2015)
Lysyl oxidase-like 2 (LOXL2) and E47 EMT factor: novel partners in E-cadherin repression and early metastasis colonization
G. Canesin et al.
ONCOGENE (2015)
Human copper-dependent amine oxidases
Joel Finney et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2014)
Ubiquitination Regulates Expression of the Serine/Arginine-rich Splicing Factor 1 (SRSF1) in Normal and Systemic Lupus Erythematosus (SLE) T Cells
Vaishali R. Moulton et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Emerging Functions of SRSF1, Splicing Factor and Oncoprotein, in RNA Metabolism and Cancer
Shipra Das et al.
MOLECULAR CANCER RESEARCH (2014)
A census of human RNA-binding proteins
Stefanie Gerstberger et al.
NATURE REVIEWS GENETICS (2014)
starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data
Jun-Hao Li et al.
NUCLEIC ACIDS RESEARCH (2014)
LOXL2 catalytically inactive mutants mediate epithelial-to-mesenchymal transition
Eva P. Cuevas et al.
BIOLOGY OPEN (2014)
Insulin-like growth factor 2 mRNA-binding proteins (IGF2BPs): post-transcriptional drivers of cancer progression?
Jessica L. Bell et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2013)
The Fragile X Protein binds mRNAs involved in cancer progression and modulates metastasis formation
Rossella Luca et al.
EMBO MOLECULAR MEDICINE (2013)
Regulation of Heterochromatin Transcription by Snail1/LOXL2 during Epithelial-to-Mesenchymal Transition
Alba Millanes-Romero et al.
MOLECULAR CELL (2013)
IGF2BP1 promotes mesenchymal cell properties and migration of tumor-derived cells by enhancing the expression of LEF1 and SNAI2 (SLUG)
Anne Zirkel et al.
NUCLEIC ACIDS RESEARCH (2013)
TAF15 is important for cellular proliferation and regulates the expression of a subset of cell cycle genes through miRNAs
M. Ballarino et al.
ONCOGENE (2013)
Regulatory networks defining EMT during cancer initiation and progression
Bram De Craene et al.
NATURE REVIEWS CANCER (2013)
Scavenger receptors in homeostasis and immunity
Johnathan Canton et al.
NATURE REVIEWS IMMUNOLOGY (2013)
HuR function in disease
Subramanya Srikantan et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2012)
LOXL2 in epithelial cell plasticity and tumor progression
Amparo Cano et al.
FUTURE ONCOLOGY (2012)
The Enzymatic Activity of Lysyl Oxidas-like-2 (LOXL2) Is Not Required for LOXL2-induced Inhibition of Keratinocyte Differentiation
Jennie Lugassy et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
The splicing factor SRSF1 regulates apoptosis and proliferation to promote mammary epithelial cell transformation
Olga Anczukow et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2012)
The rationale for targeting the LOX family in cancer
Holly E. Barker et al.
NATURE REVIEWS CANCER (2012)
Lysyl oxidase-like 2 (LOXL2), a new regulator of cell polarity required for metastatic dissemination of basal-like breast carcinomas
Gema Moreno-Bueno et al.
EMBO MOLECULAR MEDICINE (2011)
Posttranscriptional regulation of cancer traits by HuR
Kotb Abdelmohsen et al.
WILEY INTERDISCIPLINARY REVIEWS-RNA (2010)
Ubiquitin-mediated proteolysis of HuR by heat shock
Kotb Abdelmohsen et al.
EMBO JOURNAL (2009)
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
Da Wei Huang et al.
NATURE PROTOCOLS (2009)
The morphological and molecular features of the epithelial-to-mesenchymal transition
Gema Moreno-Bueno et al.
NATURE PROTOCOLS (2009)
Lysyl oxidase-like 2 as a new poor prognosis marker of squamous cell carcinomas
Hector Peinado et al.
CANCER RESEARCH (2008)
Signalling pathways regulating nucleo-cytoplasmic shuttling of the mRNA-binding protein HuR
Anke Doller et al.
CELLULAR SIGNALLING (2008)
Paradoxical roles for lysyl oxidases in cancer - A prospect
Stacey L. Payne et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2007)
Snail, ZEB and bHLH factors in tumour progression: an alliance against the epithelial phenotype?
Hector Peinado et al.
NATURE REVIEWS CANCER (2007)
Lysyl oxidase: an oxidative enzyme and effector of cell function
H. A. Lucero et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2006)
Switching on-off snail -: LOXL2 versus GSK3β
H Peinado et al.
CELL CYCLE (2005)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
A molecular role for lysyl oxidase-like 2 enzyme in Snail regulation and tumor progression
H Peinado et al.
EMBO JOURNAL (2005)
The transcription factor Slug represses E-cadherin expression and induces epithelial to mesenchymal transitions:: a comparison with Snail and E47 repressors
V Bolós et al.
JOURNAL OF CELL SCIENCE (2003)
Share Paper
